Connect with us

CEO steps down at Oragenics

May 3, 2021 - Dr. Alan Joslyn resigned as chief executive officer, president and director of Oragenics, a Tampa-based biotech firm. Joslyn resigned effective May 2 to pursue other opportunities, according to a news release from the company. Before a new CEO is hired, the board of directors will provide direction to the company, with Dr. Frederick Telling transitioning from chairman of the board to the newly established position of executive chairman, effective immediately. Mike Sullivan, the company’s current chief financial officer, will serve as the company’s interim principal executive officer to address the vacancy created by Joslyn’s resignation. Oragenics recently raised $20 million from the sale of common stock and will use some of the funding to boost its research into a Covid-19 vaccine.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us:

Subscribe for Free

Share with friend

Please enter email address you want to share this article with